ArticleJournal of obstetrics and gynaecology of India2025
Aetiology and Clinical Characteristics of Primary Amenorrhoea with Hypothalamic or Pituitary Disorders at a Quaternary Hospital.
Article in Journal of obstetrics and gynaecology of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/purpose of the study: To identify the causes and clinical characteristics of women with primary amenorrhoea and hypothalamic or pituitary gland disorders. Methods: This retrospective study was conducted at a quaternary hospital in southern Thailand. The medical records of women diagnosed with primary amenorrhea and hypothalamic or pituitary gland disorders (hypogonadotropic hypogonadism [HH]) were reviewed. HH was defined as an oestradiol level of < 20 pg/mL, decreased (< 5 mIU/mL) or normal serum follicle-stimulating hormone (FSH) levels, and no organic disease of the uterus or ovaries. Results: Fifty-five women with HH were included. The median (interquartile range [IQR]) age at presentation was 18 years (range, 17-20 years). Most patients presented with primary amenorrhoea (50/55), followed by primary infertility (3/55). All women had low levels of oestradiol (5 pg/mL [5.0-12.1]), FSH (0.8 mIU/mL [0.3-3.7]), and luteinising hormone (0.5 mIU/mL [0.1-2.3]). The most common cause was hypothalamic dysfunction (80%); including congenital hypogonadotropic hypogonadism (CHH) (43.6%), constitutional delay of growth and puberty (CDGP) (14.5%), and functional hypogonadotropic hypogonadism (FHH) (10.9%). Regarding hypothalamic dysfunction, patients with CHH were significantly older than those with CDGP (20 years [17.0-26.5] vs. 16.5 years [15.8-17.2]; P = 0.014) and had significantly lower FSH levels compared to those with FHH (0.6 mIU/mL [0.3-1.0] vs. 4.5 mIU/mL [2.8-5.7]; P = 0.026). Conclusion: Hypothalamic dysfunction, particularly CHH, is the most common cause of primary amenorrhoea and HH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.